Catharina Boehme
#173,842
Most Influential Person Now
Medical scientist
Catharina Boehme's AcademicInfluence.com Rankings
Catharina Boehmemedical Degrees
Medical
#3731
World Rank
#4236
Historical Rank
Epidemiology
#848
World Rank
#883
Historical Rank
Catharina Boehmebiology Degrees
Biology
#15702
World Rank
#19743
Historical Rank
Immunology
#1083
World Rank
#1111
Historical Rank
Download Badge
Medical Biology
Why Is Catharina Boehme Influential?
(Suggest an Edit or Addition)According to Wikipedia, Catharina Boehme is the Assistant Director-General for External Relations and Governance of the World Health Organization. She previously served as WHO Chef de Cabinet, and is known for her work in developing diagnostic tests for diseases such as tuberculosis and for advocating for increased testing for the COVID-19 disease.
Catharina Boehme's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Rapid molecular detection of tuberculosis and rifampin resistance. (2010) (2232)
- Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults (2014) (1085)
- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study (2011) (1040)
- Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology (2009) (936)
- Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study (2018) (409)
- Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis (2014) (409)
- Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study (2018) (409)
- Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System (2011) (409)
- Robustness of a loop-mediated isothermal amplification reaction for diagnostic applications. (2011) (372)
- Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study. (2011) (343)
- Operational Feasibility of Using Loop-Mediated Isothermal Amplification for Diagnosis of Pulmonary Tuberculosis in Microscopy Centers of Developing Countries (2007) (340)
- Xpert MTB/RIF: a New Pillar in Diagnosis of Extrapulmonary Tuberculosis? (2011) (325)
- Rapid Diagnosis of Tuberculosis with the Xpert MTB/RIF Assay in High Burden Countries: A Cost-Effectiveness Analysis (2011) (314)
- Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? (2016) (242)
- Building a tuberculosis-free world: The Lancet Commission on tuberculosis (2019) (214)
- Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. (2008) (182)
- Rapid and Accurate Detection of Mycobacterium tuberculosis in Sputum Samples by Cepheid Xpert MTB/RIF Assay—A Clinical Validation Study (2011) (179)
- Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis. (2005) (172)
- Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment. (2013) (156)
- Rapid molecular diagnosis of pulmonary tuberculosis in children using nasopharyngeal specimens. (2012) (146)
- Impact of Xpert MTB/RIF for TB Diagnosis in a Primary Care Clinic with High TB and HIV Prevalence in South Africa: A Pragmatic Randomised Trial (2014) (137)
- Containment of Bioaerosol Infection Risk by the Xpert MTB/RIF Assay and Its Applicability to Point-of-Care Settings (2010) (135)
- Novel lipoarabinomannan point-of-care tuberculosis test for people with HIV: a diagnostic accuracy study (2019) (135)
- Defining the needs for next generation assays for tuberculosis. (2015) (118)
- Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies (2016) (115)
- A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay. (2011) (107)
- Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. (2009) (95)
- Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India (2015) (95)
- Tuberculosis Diagnostics: State of the Art and Future Directions. (2016) (84)
- Xpert® Mtb/Rif assay for pulmonary tuberculosis and rifampicin resistance in adults (2013) (81)
- Importance of diagnostics in epidemic and pandemic preparedness (2019) (78)
- Feasibility of Decentralised Deployment of Xpert MTB/RIF Test at Lower Level of Health System in India (2014) (75)
- The Lancet Commission on diagnostics: transforming access to diagnostics (2021) (75)
- Determine TB-LAM lateral flow urine antigen assay for HIV-associated tuberculosis: recommendations on the design and reporting of clinical studies (2013) (74)
- Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action. (2013) (58)
- Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB (2014) (58)
- Evaluation of Xpert MTB/RIF for Detection of Tuberculosis from Blood Samples of HIV-Infected Adults Confirms Mycobacterium tuberculosis Bacteremia as an Indicator of Poor Prognosis (2013) (56)
- Multicenter Noninferiority Evaluation of Hain GenoType MTBDRplus Version 2 and Nipro NTM+MDRTB Line Probe Assays for Detection of Rifampin and Isoniazid Resistance (2016) (55)
- Addressing the challenges of diagnostics demand and supply: insights from an online global health discussion platform (2016) (46)
- Evaluation of Genotype MTBDRsl Assay to Detect Drug Resistance Associated with Fluoroquinolones, Aminoglycosides and Ethambutol on Clinical Sediments (2012) (42)
- Diagnostic preparedness for infectious disease outbreaks (2017) (42)
- Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population (2015) (40)
- The Changing Landscape of Diagnostic Services for Tuberculosis (2013) (39)
- Catching the Missing Million: Experiences in Enhancing TB & DR-TB Detection by Providing Upfront Xpert MTB/RIF Testing for People Living with HIV in India (2015) (39)
- Feasibility and Operational Performance of Tuberculosis Detection by Loop-Mediated Isothermal Amplification Platform in Decentralized Settings: Results from a Multicenter Study (2016) (38)
- Congenital Visceral Leishmaniasis (2006) (33)
- Target product profile of a molecular drug-susceptibility test for use in microscopy centers. (2015) (32)
- Comparative performance of four rapid Ebola antigen-detection lateral flow immunoassays during the 2014-2016 Ebola epidemic in West Africa (2019) (31)
- A prospective multicentre diagnostic accuracy study for the Truenat tuberculosis assays (2021) (31)
- Diagnosis of opportunistic infections: HIV co-infections – tuberculosis (2017) (30)
- Factors Associated with Tuberculosis and Rifampicin-Resistant Tuberculosis amongst Symptomatic Patients in India: A Retrospective Analysis (2016) (26)
- An evaluation framework for new tests that predict progression from tuberculosis infection to clinical disease (2018) (26)
- The Potential Impact of Up-Front Drug Sensitivity Testing on India’s Epidemic of Multi-Drug Resistant Tuberculosis (2015) (26)
- Connectivity of diagnostic technologies: improving surveillance and accelerating tuberculosis elimination. (2016) (25)
- Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India (2018) (22)
- Bottom-up or top-down: unit cost estimation of tuberculosis diagnostic tests in India. (2017) (21)
- “Before Xpert I only had my expertise”: A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities (2018) (21)
- SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings (2021) (20)
- Analytical and Clinical Evaluation of the Epistem Genedrive Assay for Detection of Mycobacterium tuberculosis (2016) (18)
- An Appeal to the Global Health Community for a Tripartite Innovation: An "Essential Diagnostics List," "Health in All Policies," and "See-Through 21(st) Century Science and Ethics". (2015) (15)
- Availability of essential diagnostics in primary care in India. (2018) (14)
- Diagnostic Infectious Diseases Testing Outside Clinics: A Global Systematic Review and Meta-analysis (2020) (13)
- Aiming for zero tuberculosis transmission in low-burden countries. (2017) (13)
- Essential medicines and essential diagnostics: a package deal. (2019) (12)
- Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation (2018) (11)
- Need to confirm isoniazid susceptibility in Xpert MTB/RIF rifampin susceptible cases (2012) (11)
- Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India (2019) (9)
- Comparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study (2017) (8)
- Market assessment of tuberculosis diagnostics in China in 2012. (2016) (8)
- Promoting diagnostics as a global good (2021) (8)
- Application of a simple point-of-care test to reduce UK healthcare costs and adverse events in outpatient acute respiratory infections (2020) (8)
- Market assessment of tuberculosis diagnostics in India in 2013. (2016) (7)
- Tuberculosis Diagnostics in the New Millennium: Role in TB Identification and Control (2012) (7)
- Evaluation of Diagnos TB AG, a flow-through immunoassay for rapid detection of pulmonary tuberculosis. (2010) (7)
- Availability of essential diagnostics at primary care public clinics in Peru. (2020) (7)
- Precision global health: a roadmap for augmented action (2020) (6)
- Upfront Xpert MTB/RIF for diagnosis of pediatric TB—Does it work? Experience from India (2020) (6)
- Catalysing progressive uptake of newer diagnostics by health care providers through outreach and education in four major cities of India (2018) (5)
- Xpert MTB/RIF, a new pillar in the diagnosis of (2011) (5)
- Novel High Sensitivity Tuberculosis Point-of-Care Test for People Living with HIV (2018) (5)
- Tuberculosis prevention must integrate technological and basic care innovation (2016) (5)
- Transforming TB diagnosis: can patients and control programs afford to wait? (2012) (3)
- Xpert MTB/RIF test for tuberculosis – Authors' reply (2011) (3)
- Aligning New Tuberculosis Drug Regimens and Drug Susceptibility Testing: A Needs Assessment and Roadmap for Action (2014) (3)
- Congenital visceral leishmaniasis [letter] (2006) (3)
- Diagnostic testing holds the key to NTD elimination (2021) (3)
- How to fix tuberculosis R&D—the community speaks (2019) (2)
- Multi-center Study to Assess the Non-inferiority of Nipro NTM + MDRTB and Hain Genotype Mtbdrplus V2 Line Probe Assays Compared to Hain Genotype Mtbdrplus V1 (2015) (2)
- Cartridge-Based Automated Nucleic Acid Amplification Test (Xpert MTB/RIF) For The Diagnosis Of Pulmonary Tuberculosis In HIV-Infected And Uninfected Children: A Prospective Study (2011) (2)
- TB and women: a call to action. (2020) (2)
- Rapid Molecular Diagnosis Of Pulmonary Tuberculosis In Children Using Nasopharyngeal Specimens (2012) (1)
- S08.1 Diagnostic Infectious diseases self-testing and self-sampling outside clinics: A global systematic review (2021) (0)
- How to fix tuberculosis R&D—the community speaks (2019) (0)
- CONFRONTING ANTIMICROBIAL RESISTANCE (2015) (0)
- Performance of The Truenat Tuberculosis and Rifampicin-Resistance Assays in the Microscopy Centre: A Prospective Multicentre Diagnostic Accuracy Study (2020) (0)
- William an Indicator of Poor Prognosis Mycobacterium tuberculosis Bacteremia as HIV-Infected Adults Confirms of Tuberculosis from Blood Samples of Evaluation of Xpert MTB / RIF for Detection (2013) (0)
This paper list is powered by the following services:
Other Resources About Catharina Boehme
What Schools Are Affiliated With Catharina Boehme?
Catharina Boehme is affiliated with the following schools:
